A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Amlodipine Besylate and Valsartan 10/160 mg Film-coated Tablets and Reference Product (Exforge) in Healthy Thai Volunteers under Fasting Conditions
Optimal Medical Treatment of Difficult-to-treat Hypertension
The purpose of this study is to evaluate best medical management to achieve the BP goals of ESC/ESH (120-129 / 70-79 mmHg) in HT patients who are <65 years old and ineffectively treated (BP ≥ 130/80 mg) with 3 or more antihypertensive drugs
Start Date20 Oct 2023
Sponsor / Collaborator-
100 Clinical Results associated with VDCCs x NCC x AT1R
Login to view more data
100 Translational Medicine associated with VDCCs x NCC x AT1R
Login to view more data
0 Patents (Medical) associated with VDCCs x NCC x AT1R
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.